Loading...
Endurance of erythrocyte series in chemotherapy
Hematopoietic bone marrow toxicity is most often the limiting factor for chemotherapy doses. Increasing the intensity of chemotherapy doses (higher doses or more frequent administration) would improve antitumor effects, but the hematological toxicity does not allow these dose increases. This study e...
Na minha lista:
| Udgivet i: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604759/ https://ncbi.nlm.nih.gov/pubmed/33149778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9344 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|